Loomis, Sayles & Company
SHC icon

Loomis, Sayles & Company’s Sotera Health SHC Stock Holding History

Loomis, Sayles & Company’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-367
Closed -$6K – 927
2023
Q4 		$6K Buy
+367
New +$5.2K ﹤0.01% 867
2022
Q2 		– Sell
-129
Closed -$3K – 1041
2022
Q1 		$3K Buy
+129
New +$2.74K ﹤0.01% 899

Other funds holding SHC

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
MC
MIG Capital Newport Beach, California $589M AUM 25.96% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Loomis, Sayles & Company's SHC Position: Q1 2024 in Review

Loomis, Sayles & Company sold out of Sotera Health (SHC) in Q1 2024, closing a stake of 367 shares — an estimated $6K sold.

Loomis, Sayles & Company first reported a position in SHC in Q1 2022 and held it in 2 quarters. The position peaked at $6K in Q4 2023. 196 funds tracked by Wall St. Rank hold SHC as of Q1 2024.

  • Loomis, Sayles & Company reported no remaining Sotera Health position as of Q1 2024 after selling out during the quarter.
  • Loomis, Sayles & Company sold 367 Sotera Health shares in Q1 2024, an estimated $6K.
  • Loomis, Sayles & Company first reported a position in Sotera Health in Q1 2022 and held it in 2 quarters.
  • Loomis, Sayles & Company's Sotera Health position peaked at $6K in Q4 2023.
  • 196 funds tracked by Wall St. Rank held Sotera Health as of Q1 2024.

Based on Loomis, Sayles & Company's 13F filing for Q1 2024, filed 14 May 2024.